my account
log out
|
|
my account
log out
|
BAFF-DT immunotoxin |
| Create: 03/30/2017 |
| Expired Date: | 03/12/2019 |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | This immunotoxin was achieved by conjugating/fusing the BAFF to Diphtheriatoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to BCMA expressing B cells. Once bind, the toxin enters cells by receptor-mediated endocytosis, then Before the N-terminal 193 amino acids corresponding to the catalytic domain of DT enzyme; -II binding and elongation factor into the eukaryotic cell; the cell can catalyze specific elongation factor EF2 amide His699 of diphtheria ADP2 ribosylation occurs; thereby preventing protein synthesis and causes cell death. It was designed for treatment of B cell leukemias. |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 232 | |
| Feb 01 2023 | GVBE Buffer | 232 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 239 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 227 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 420 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 502 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 411 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 428 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 409 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 437 |
| Copyright © toextrade Inc. All rights reserved. Contact us |